Shiguang Liu
The Kidney Institute
University of Kansas Medical Center
3901 Rainbow Blvd.
Kansas City
USA
Name/email consistency: high
- Pathogenic role of Fgf23 in Dmp1-null mice. Liu, S., Zhou, J., Tang, W., Menard, R., Feng, J.Q., Quarles, L.D. Am. J. Physiol. Endocrinol. Metab. (2008)
- FGFR3 and FGFR4 do not mediate renal effects of FGF23. Liu, S., Vierthaler, L., Tang, W., Zhou, J., Quarles, L.D. J. Am. Soc. Nephrol. (2008)
- Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice. Liu, S., Tang, W., Zhou, J., Vierthaler, L., Quarles, L.D. Am. J. Physiol. Endocrinol. Metab. (2007)
- Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity. Liu, S., Rowe, P.S., Vierthaler, L., Zhou, J., Quarles, L.D. J. Endocrinol. (2007)
- Pathogenic role of Fgf23 in Hyp mice. Liu, S., Zhou, J., Tang, W., Jiang, X., Rowe, D.W., Quarles, L.D. Am. J. Physiol. Endocrinol. Metab. (2006)
- Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. Liu, S., Tang, W., Zhou, J., Stubbs, J.R., Luo, Q., Pi, M., Quarles, L.D. J. Am. Soc. Nephrol. (2006)
